Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking

Journal of Clinical Psychopharmacology

Volumn 14, Issue 1, 1994, Pages 41-49

  Levin, Edward D ^a   Westman, Eric C ^b   Stein, Roy M ^a,b   Carnahan, Elizabeth ^a   Sanchez, Matthew ^a   Herman, Steve ^a   Behm, Frederique M ^a   Rose, Jed E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; APPETITE; AROUSAL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN; SKIN IRRITATION; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; AROUSAL; BREATH TESTS; CARBON MONOXIDE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NICOTINE; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0028215585     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/00004714-199402000-00006     Document Type: Article

References (24)

1. Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN, Cheney RA, Hatlelid K, Thompson AB, Rennard SI. Effect of transdermal nicotine delivery as an adjunct to lowintervention smoking cessation therapy. Arch Intern Med 1991;151:749–52.
2. Hurt RD, Lauger GG, Offord KP, Kottke TE, Dale LC. Nicotine replacement therapy with use of a transdermal nicotine patch—a randomized double-blind placebo-controlled trial. Mayo Clin Proc 1990;65:1529–37.
3. Muller P, Imhof PR, Mauli D, Milovanovic D. Human pharmacological investigations of a transdermal nicotine system. Meth Find Exp Clin Pharmacol 1989;11:197–204.
4. Mulligan SC, Masterson JG, Devane JG, Kelly JG. Clinical and pharmacokinetic properties of a transdermal patch. Clin Pharmacol Ther 1990;47:331–7.
5. Rose JE, Levin ED, Behin FM, Adivi C, Schur C. Transdermal nicotine facilitates smoking cessation. Clin Pharmacol Ther 1990;47:323–30.
6. Tdnnesen P, NArregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991;325:311–5.
7. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six month results from two multicenter controlled clinical trials. JAMA 1991;266:3133–8.
8. Westman E, Levin E, Rose J. Effectiveness of the nicotine patch in smoking cessation: a randomized controlled trial with telephone counseling. Arch Intern Med 1993;153:1917–23.
9. Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992; 44:498–529.
10. Breslau N, Kilbey M, Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry 1991;48:1069–74.
11. Breslau N, Kilbey MM, Andreski P. Nicotine dependence and major depression—new evidence from a prospective investigation. Arch Gen Psychiatry 1993;50:31–5.
12. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986;143:993–7.
13. Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: fmdings from an epidemiologic study of young adults. Am J Psychiatry 1992;149:464–9.
14. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Comp Psychiatry 1990;31:350–4.
15. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J. Smoking, smoking cessation, and major depression. JAMA 1990;264:1546–9.
16. Kendler KS, Neale MC, Maclean CJ, Heath AC, Eaves IJ, Kessler RC. Smoking and major depression—a causal analysis. Arch Gen Psychiatry 1993;50:36–43.
17. Beck A. Beamsderfer A. Assessment of depression: The depression inventory. In: Pichot P ed. Psychological measurement in psychopharmacology, modem problems in pharmacopsychiatry. Basel: Karge, 1974:151–69.
18. Shiffman SM, Jarvik JE. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 1976;50:35–9.
19. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385–96.
20. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Personality Soc Psychol 1988;54:1063–70.
21. Beck A. Steer R, Garbin M. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol 1988;8:77–100.
22. Marlatt GA, Gordon JR. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford; 1985.
23. Westman EC, Levin ED, Rose JE. Smoking while wearing the patch: is smoking satisfying or harmful? Clin Res 1992;40:811A.
24. Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MAH. Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology 1992;106:421–7.